SHFA Pharmacy

SHFA Pharmacy SHFA is one of the leading pharmacies in the Syria.

27/09/2020

Don’t forget to check our new products ..

  Why is the medical world excited about it? Because the cheap and widely available steroid is a potential life-saving d...
27/09/2020



Why is the medical world excited about it? Because the cheap and widely available steroid is a potential life-saving drug for critically ill COVID-19 patients. That’s what the researchers at the University of Oxford discovered.

In their study, the drug has been found to reduce the mortality of the sickest patients. Which is more like virtually pulling them away from the doorstep of death.

The medication is of no use to corona patients with mild symptoms, but that doesn’t matter. They don’t require hospitalisation. No medicines too, as their treatment is more symptomatic.

Critically ill patients
COVID-19 patients are generally hospitalized only when their lungs are affected. They will require assisted breathing. A patient on a ventilator is at a critical stage. So when a drug reduces deaths by one-third, that is enough cause for jubilation. It’s a life-saver! Until now, there have been no effective drugs to treat these dying patients. The drug is also found to be effective for patients who need oxygen support.

60000SP to save a life
Prof Martin Landry, co-leading the trial, said the findings indicate that one life could be saved for £35. That would be around 60000SP
“The treatment is up to 10 days of dexamethasone. It costs in the order of £5 for a complete course of treatment in the NHS,” he was quoted as saying.

“For less than £50 pounds, you can treat eight patients and save a life,” he said in an online briefing. One death would be prevented in every 25 COVID-19 patients on oxygen that received the drug, he calculated.

Can everyone use dexamethasone?
No, it works only on COVID-19 patients hospitalized with breathing difficulties. Which means they will be on ventilators or oxygen support.

People with mild illness are treated symptomatically. In most cases, paracetamol is enough.

The team of scientists at the Florey Institute of Neuroscience and Mental Health expected that the spread of the Corona ...
27/09/2020

The team of scientists at the Florey Institute of Neuroscience and Mental Health expected that the spread of the Corona virus would increase a person's risk of developing Parkinson's disease (Parkinson), according to the "New Atlas" website.

Parkinson's disease is a chronic disease that increases in severity with time and affects millions around the world, and causes involuntary shivering and problems with walking and speaking due to damage to dopamine-producing brain cells.

According to the study, there are increasing reports that prove that the Corona virus is a neurotransmitter virus, which means that it has the ability to enter brain tissue.

This indicates that the emerging corona virus certainly has the potential to act as a "feedstock" pathogen to increase the risk of developing Parkinson's disease.

The researchers also pointed to the repercussions of the 1918 Spanish influenza pandemic as evidence for this hypothesis, as 5 years after the end of the Spanish flu pandemic, the global diagnosis of Parkinson's disease has nearly doubled 3 times.

Posted on our website on: 24/9/2020

Address

Yabroûd

Website

Alerts

Be the first to know and let us send you an email when SHFA Pharmacy posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to SHFA Pharmacy:

Share